Nice app
Nice information!!!
SITC Immunotherapy Guidelines
Veröffentlicht von: SOCIETY FOR IMMUNOTHERAPY OF CANCER
Downloads
Umsatz
Beschreibung
The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG App features evidence- and expert consensus based-recommendations on all aspects of immunotherapy treatment as well as interactive tools and companion educational resources. From biomarkers and therapy selection to quality of life and management of immune-related adverse events, busy clinicians will find the SITC CPG App as the go-to resource on when and how to use immunotherapy to help improve outcomes for patients with cancer.
Key App Features
*Clean and simple navigation with a modern interface
*Interactive tools and tables at your fingertips
*Advanced search functionality for fast access to the content clinicians need
*Bookmarking and annotation capabilities throughout for future fast-reference
*Timely updates when new practice-changing data or approvals become available
*Companion educational offerings to enhance understanding of guideline recommendations
*Free download with open-access content
About SITC’s Guidelines
SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.
About SITC
SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org
sitcancer.org/CPG-app
On social - #SITCGuidelines
Ausblenden
Mehr anzeigen...
Key App Features
*Clean and simple navigation with a modern interface
*Interactive tools and tables at your fingertips
*Advanced search functionality for fast access to the content clinicians need
*Bookmarking and annotation capabilities throughout for future fast-reference
*Timely updates when new practice-changing data or approvals become available
*Companion educational offerings to enhance understanding of guideline recommendations
*Free download with open-access content
About SITC’s Guidelines
SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.
About SITC
SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org
sitcancer.org/CPG-app
On social - #SITCGuidelines
Screenshots
SITC Immunotherapy Guidelines Häufige Fragen
-
Ist SITC Immunotherapy Guidelines kostenlos?
Ja, SITC Immunotherapy Guidelines ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.
-
Ist SITC Immunotherapy Guidelines seriös?
Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.
Danke für die Stimme -
Wie viel kostet SITC Immunotherapy Guidelines?
SITC Immunotherapy Guidelines ist kostenlos.
-
Wie hoch ist der Umsatz von SITC Immunotherapy Guidelines?
Um geschätzte Einnahmen der SITC Immunotherapy Guidelines-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.
Benutzerbewertung
Die App ist in Sonderverwaltungsregion Hongkong noch nicht bewertet.
Bewertungsverlauf
SITC Immunotherapy Guidelines Bewertungen
Store-Rankings
Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
|
Diagramm
|
Kategorie
|
Rang
|
|---|---|---|
|
Top Kostenlos
|
|
195
|
SITC Immunotherapy Guidelines Konkurrenten
| Name | Downloads (30d) | Monatlicher Umsatz | Rezensionen | Bewertungen | Letzte Veröffentlichung | |
|---|---|---|---|---|---|---|
HemeOncBuddy
hemeonc trials
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Jahr | |
ASTCT Practice Guidelines
|
Freischalten
|
Freischalten
|
0
|
|
vor 4 Monaten | |
ESMO Interactive Guidelines
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Jahr | |
Immuno-Oncology
from @ Point of Care™
|
Freischalten
|
Freischalten
|
1
|
|
vor 4 Monaten | |
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
|
Freischalten
|
Freischalten
|
0
|
|
vor 6 Monaten | |
ASCO Guidelines
|
Freischalten
|
Freischalten
|
0
|
|
vor 1 Jahr | |
CARTOX
Toxicity assessment tool
|
Freischalten
|
Freischalten
|
0
|
|
vor 2 Jahren | |
ASH Pocket Guides
|
Freischalten
|
Freischalten
|
0
|
|
vor 9 Monaten | |
Hem/Onc @Point of Care
Hematology & Oncology
|
Freischalten
|
Freischalten
|
0
|
|
vor 4 Monaten | |
ASCO-SEP®
ASCO Self-Evaluation Program
|
Freischalten
|
Freischalten
|
0
|
|
vor 4 Monaten |
SITC Immunotherapy Guidelines Installationen
Letzte 30 Tage
SITC Immunotherapy Guidelines Umsatz
Letzte 30 TageSITC Immunotherapy Guidelines Einnahmen und Downloads
Gewinnen Sie wertvolle Einblicke in die Leistung von SITC Immunotherapy Guidelines mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
App-Informationen
- Kategorie
- Medical
- Herausgeber
- SOCIETY FOR IMMUNOTHERAPY OF CANCER
- Sprachen
- English, German
- Letzte Veröffentlichung
- 1.7 (vor 8 Monaten )
- Veröffentlicht am
- Aug 30, 2021 (vor 3 Jahren )
- Auch verfügbar in
- Vereinigte Staaten, Indien, Deutschland, Vereinigtes Königreich, Italien, Portugal, China, Australien, Norwegen, Rumänien, Russland, Vietnam, Indonesien, Polen, Griechenland, Frankreich, Finnland, Saudi-Arabien, Südkorea, Dänemark, Türkei, Taiwan, Schweiz, Kanada, Belgien, Peru, Neuseeland, Nigeria, Niederlande, Südafrika, Philippinen, Pakistan, Schweden, Singapur, Thailand, Ukraine, Vereinigte Arabische Emirate, Ägypten, Österreich, Aserbaidschan, Brasilien, Belarus, Chile, Kolumbien, Tschechien, Dominikanische Republik, Algerien, Ecuador, Malaysia, Spanien, Sonderverwaltungsregion Hongkong, Ungarn, Irland, Israel, Japan, Kuwait, Kasachstan, Libanon, Mexiko
- Zuletzt aktualisiert
- vor 12 Stunden
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.
- © 2024 AppTail.
- Unterstützung
- Privacy
- Terms
- All Apps